Skip to main content

CDC Recommendations on Shared Clinical Decision-Making

May 21, 2020

To: All Primary Care

When it comes to discussing vaccinations with your BlueCross BlueShield patients, the Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) suggests a shared provider and patient decision approach about the appropriateness of certain immunizations.

ACIP recommends that decisions to vaccinate adults 27-45 years old for Human papillomavirus (HPV) and healthy adults 65 and older for pneumococcal (PCV13) should be based on “shared clinical decision making.” Shared clinical decision-making refers to patients and their provider discussing and deciding together the appropriateness of receiving certain vaccines and are based on the individual.

Please note: the CDC identifies shared clinical decision-making as separate from routine, follow-up, and risk-based recommendations.

Generally, ACIP makes shared clinical decision-making recommendations when individuals may benefit from a vaccination, but broad vaccination of people in that group are unlikely to have population-level impacts.

CDC guidance recommends shared clinical decision-making be considered based on:

  • When a vaccine is not a default option or risk-related recommendation based on the age group or other indication
  • The individual’s characteristics, values, and preferences
  • The provider’s clinical discretion
  • The characteristics of the vaccine being considered

Shared clinical decision-making is suggested for vaccines like HPV for adults between 27-45 because while it may be beneficial to those individuals, it is often less effective in older age groups who have lower risk of infection exposure whereas it is most effective when given to adolescents prior to age 13.

Please note: while the CDC recommends shared clinical decision-making for adult immunization for HPV, the American Cancer Society, NYS and City Departments of Health encourage patients between 11 and 12 to receive the HPV vaccine.

The HPV and pneumococcal vaccines are both covered for your BlueCross BlueShield patients.

The link below offers more information and guidance on shared clinical decision-making.

Recent Articles

  • Individual Provider Recontracting Initiative
    We will be amending and restating our existing contracts. Starting next month, all directly contracted individual providers will be sent an updated contract. The New York State Department of Health (DOH) requires that each provider sign and return their amended/restated contract.
  • New Digital Provider and Facility Reference Manual
    We’ve upgraded our Provider and Facility Reference Manual, which is now available in digital format. The new manual offers a better, more interactive user experience. Here, we highlight some of the new features.
  • Updates to Screening for Hepatitis C Virus (HCV) in Adults
    Hepatitis C virus (HCV) is reportedly the most common blood infection in the country. The U.S. Preventive Services Task Force has updated the recommendation for HCV screening in March 2020 to now include all adults ages 18 to 79 without known liver disease, regardless of their risk for infection.
  • Update to Spine Preauthorization Process
    To help streamline the preauthorization process for spine procedures and injections, all these requests will be submitted directly to our Utilization Management Department beginning October 1, 2020. We will no longer require any requests to be submitted through Palladian Health.
  • Care at Home Expanded for Medicare Advantage Patients
    Beginning on July 7, more Medicare Advantage patients will be eligible to enroll in a new extension of the Care at Home program -- Care at Home℠ On Call -- which offers some urgent care in-home services. Care at Home On Call will be offered to newly enrolled Medicare Advantage members.

Working with Us

Additional Resources

We want to hear from you! Have a topic request for the next Blue Bulletin? Email us

Stay in Touch! Sign up to receive emails for provider news and information